References
- Schnell O, Barnard K, Bergenstal R, et al. Clinical utility of SMBG: recommendations on the use and reporting of SMBG in clinical research. Diabetes Care. 2015;38(9):1627–1633.
- American Diabetes Association. Glycemic targets: standards of medical care in diabetes – 2019. Diabetes Care. 2019;42(Suppl 1):S61–S70.
- Erbach M, Freckmann G, Hinzmann R, et al. Interferences and limitations in blood glucose self-testing: an overview of the current knowledge. J Diabetes Sci Technol. 2016;10(5):1161–1168.
- Freckmann G, Jendrike N, Baumstark A, et al. User performance evaluation of four blood glucose monitoring systems applying ISO 15197:2013 accuracy criteria and calculation of insulin dosing errors. Diabetes Ther. 2018;9(2):683–697.
- Ginsberg BH. Factors affecting blood glucose monitoring: sources of errors in measurement. J Diabetes Sci Technol. 2009;3(4):903–913.
- Liberman A, Barnard K. Diabetes technology and the human factor. Diabetes Technol Ther. 2018;20(S1):S128–S138.
- Campos-Náñez E, Breton MD. Effect of BGM accuracy on the clinical performance of CGM: an in-silico study. J Diabetes Sci Technol. 2017;11(6):1196–1206.
- Walsh J, Roberts R, Weber D, et al. Insulin pump and CGM usage in the United States and Germany: results of a real-world survey with 985 subjects. J Diabetes Sci Technol. 2015;9(5):1103–1110.
- International Organization for Standardization. Technical committee ISO/TC 212. Standards catalogue. ISO 15197:2013(en): in vitro diagnostic test systems – requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. (Last reviewed and confirmed 2018). Edition 2. Geneva, Switzerland: ISO. 2013-05: 46pp.
- International Organization for Standardization. Technical committee ISO/TC 21233. ISO 15197:2003(en): in vitro diagnostic test systems – requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus (withdrawn). Edition 1. Geneva, Switzerland: ISO. 2003-05: 33pp.
- Freckmann G, Schmid C, Baumstark A, et al. Analytical performance requirements for systems for self-monitoring of blood glucose with focus on system accuracy: relevant differences among ISO 15197:2003, ISO 15197:2013, and current FDA recommendations. J Diabetes Sci Technol. 2015;9(4):885–894.
- Pardo S, Dunne N, Simmons DA. Using radar plots to demonstrate the accuracy and precision of 6 blood glucose monitoring systems. J Diabetes Sci Technol. 2017;11(5):966–969.
- Parkes JL, Slatin SL, Pardo S, et al. A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care. 2000;23(8):1143–1148.
- Draper NR, Smith H. Applied regression analysis. 3rd edition. New York: John Wiley and Sons; 1998.
- King P, Peacock I, Donnelly R. The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 2001;48(5):643–648.
- Tonyushkina K, Nichols JH. Glucose meters: a review of technical challenges to obtaining accurate results. J Diabetes Sci Technol. 2009;3(4):971–980.
- Strain W, Bluher M, Paldanius P. Clinical inertia in individualising care for diabetes: is there time to do more in type 2 diabetes? Diabetes Ther. 2014;5(2):347–354.
- Jones J, Caird J. The usability of blood glucose meters: task performance differences between younger and older age groups. Proc Hum Factors Ergonomics Soc Annual Meet. 2017;61(1):604–608.
- Heinemann L, Stuhr A, Brown A, et al. Self-measurement of blood glucose and continuous glucose monitoring – is there only one future?. Eur Endocrinol. 2018;14(2):24–29.